Resources

Past Presentation

The Impact of SVR on Cirrhosis and Non-Liver Complications | December 11, 2018

Date of Presentation: December 11, 2018

Type: Past Presentation  

Audience: Clinical  

Program: Hepatitis C  

Keywords: #cirrhosis  #direct acting antiviral  #interferon treatment  #liver disease  #sustained virologic response  

Annette Hewitt and Lisa Townshend-Bulson, Family Nurse Practitioners from the Alaska Native Tribal Health Consortium, Liver Disease & Hepatitis Program, present on the impact of sustained virologic response (SVR) on cirrhosis and non-liver complications in both direct acting antiviral (DAA) and interferon-based treatments.

Presented by:

Annette Hewitt, Lisa Townshend-Bulson

Annette Hewitt, ANRP, FNP-BC, is a family nurse practitioner specializing in the treatment of patients with Hepatitis C. She currently practices at the Alaska Native Tribal Health Consortium, Liver Disease & Hepatitis Program. She earned both a Bachelor and Master of Science in Nursing from UAA. Annette has over 20 years of experience as a nurse practitioner.

Lisa Townshend-Bulson, ANRP, FNP-BC, is the Clinical Manager for the ANTHC Liver Disease & Hepatitis Program where she practices as a nurse practitioner, participates in program management, and as a clinical investigator in liver disease research. She has been a major contributor to the Alaska Native Tribal Health Consortium Liver Disease and Hepatitis Program. She holds a Master’s Degree in Nursing/Family Nurse Practitioner and is certified as a Family Nurse Practitioner by the American Association of Nurse Practitioners. Lisa is a member of the American Association for the Study of Liver Diseases and the American Academy of Nurse Practitioners.

Resources Provided:

Date added: December 11, 2018